Sophie Sayon

Impact of Y143 HIV-1 Integrase Mutations on Resistance to Raltegravir <i>In Vitro</i> and <i>In Vivo</i>

Olivier Delelis, Sylvain Thierry, Frédéric Subra et al. · Antimicrobial Agents and Chemotherapy · 2009 · 75 citations · Full text

Life Sciences, Genetics, Infectious Diseases +17

Partially active HIV-1 Vif alleles facilitate viral escape from specific antiretrovirals

Slim Fourati, Isabelle Malet, Mawuena Binka et al. · AIDS · 2010 · 65 citations · Full text

Life Sciences, Infectious Diseases, Molecular Genetics +17

TLR-2 Recognizes Propionibacterium acnes CAMP Factor 1 from Highly Inflammatory Strains

C. Lheure, P. Grange, Guillaume Ollagnier et al. · PLoS ONE · 2016 · 65 citations · Full text

Life Sciences, Immunology, Microbiology +17

E138K and M184I mutations in HIV-1 reverse transcriptase coemerge as a result of APOBEC3 editing in the absence of drug exposure

Slim Fourati, Isabelle Malet, Sidonie Lambert et al. · AIDS · 2012 · 50 citations

Life Sciences, Molecular Genetics, Pharmacology +17

Higher efficacy of nevirapine than efavirenz to achieve HIV-1 plasma viral load below 1 copy/ml

Stéphanie Haïm‐Boukobza, Laurence Morand‐Joubert, Philippe Flandre et al. · AIDS · 2010 · 49 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17